Ángeles G. Estrada-Vega
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ángeles G. Estrada-Vega has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Carlo Franco Medina-Ramirez
Instituto Politécnico Nacional, Centro de Biotecnología Genómica, Reynosa 88710, Mexico
1 shared publication - Diego Torres-Morales
Escuela de Medicina, Universidad de Monterrey, Monterrey 64460, Mexico
1 shared publication - Eli Fuentes-Chávez
Centro de Estudios e Investigaciones Interdisciplinarios, Universidad Autónoma de Coahuila, Saltillo 25280, Mexico
1 shared publication - Enrique Rodríguez-Díaz
Escuela de Medicina, Universidad de Monterrey, Monterrey 64460, Mexico
1 shared publication - Jose L. Chavelas-Reyes
Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa 88710, Mexico
1 shared publication - Josefina Guadalupe Rodríguez-González
Centro de Estudios e Investigaciones Interdisciplinarios, Universidad Autónoma de Coahuila, Saltillo 25280, Mexico
1 shared publication
Latest Publications
- Open Access
- 25 October 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (11) , 2453
Molecular Epidemiology of Mycobacterium tuberculosis in Mexico
Tuberculosis (TB), caused by Mycobacterium tuberculosis, continues to be a leading cause of morbidity and mortality in Mexico, with more than 20,000 new cases annually and a rising proportion of drug-resistant strains. This work addresses the molecular epidemiology of TB in the Mexican context, emphasizing its role in understanding transmission, genetic diversity, and resistance mechanisms. To achieve this, we reviewed molecular typing approaches including spoligotyping, Mycobacterial Interspersed Repetitive Unit–Variable Number Tandem Repeat (MIRU-VNTR) analysis, and whole-genome sequencing (WGS), which have been applied to characterize circulating lineages and identify drug-resistance-associated mutations. The results indicate that the Euro-American lineage (L4) predominates across the country, although significant regional variation exists, with Haarlem, LAM, T, and X sub lineages dominating in different states, and occasional detection of Asian (L2) and Indo-Oceanic (L1) lineages. Key resistance mutations were identified in katG, rpoB, pncA, and gyrA, contributing to the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, particularly in border and marginalized regions. These findings highlight how social factors, such as migration, urban overcrowding, and comorbidities including diabetes and HIV, influence transmission dynamics. We conclude that integrating molecular tools with epidemiological surveillance is crucial for strengthening public health strategies and guiding interventions tailored to Mexico’s heterogeneous TB burden.
- 25 October 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (11) , 2453
Open AccessMolecular Epidemiology of Mycobacterium tuberculosis in Mexico
Tuberculosis (TB), caused by Mycobacterium tuberculosis, continues to be a leading cause of morbidity and mortality in Mexico, with more than 20,000 new cases annually and a rising proportion of drug-resistant strains. This work addresses the molecular epidemiology of TB in the Mexican context, emphasizing its role in understanding transmission, genetic diversity, and resistance mechanisms. To achieve this, we reviewed molecular typing approaches including spoligotyping, Mycobacterial Interspersed Repetitive Unit–Variable Number Tandem Repeat (MIRU-VNTR) analysis, and whole-genome sequencing (WGS), which have been applied to characterize circulating lineages and identify drug-resistance-associated mutations. The results indicate that the Euro-American lineage (L4) predominates across the country, although significant regional variation exists, with Haarlem, LAM, T, and X sub lineages dominating in different states, and occasional detection of Asian (L2) and Indo-Oceanic (L1) lineages. Key resistance mutations were identified in katG, rpoB, pncA, and gyrA, contributing to the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, particularly in border and marginalized regions. These findings highlight how social factors, such as migration, urban overcrowding, and comorbidities including diabetes and HIV, influence transmission dynamics. We conclude that integrating molecular tools with epidemiological surveillance is crucial for strengthening public health strategies and guiding interventions tailored to Mexico’s heterogeneous TB burden.